Christopher J. Wraight

1.6k total citations
31 papers, 1.3k citations indexed

About

Christopher J. Wraight is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Christopher J. Wraight has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cell Biology. Recurrent topics in Christopher J. Wraight's work include Growth Hormone and Insulin-like Growth Factors (14 papers), RNA Interference and Gene Delivery (6 papers) and Fibroblast Growth Factor Research (5 papers). Christopher J. Wraight is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (14 papers), RNA Interference and Gene Delivery (6 papers) and Fibroblast Growth Factor Research (5 papers). Christopher J. Wraight collaborates with scholars based in Australia, United States and Canada. Christopher J. Wraight's co-authors include George A. Werther, Stephanie R. Edmondson, P.K. Bos, Keith K. Stanley, Paul J. White, Nicholas J. Hoogenraad, Jennifer L. Wilkinson‐Berka, Rhys D. Fogarty, Mari Murashita and Joachim Lipp and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Nature Biotechnology.

In The Last Decade

Christopher J. Wraight

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Wraight Australia	21	683	313	280	247	130	31	1.3k
Ignacio Benedicto Spain	22	642 0.9×	99 0.3×	192 0.7×	237 1.0×	93 0.7×	37	1.6k
Eiji Takayama Japan	19	652 1.0×	54 0.2×	123 0.4×	582 2.4×	119 0.9×	62	1.5k
Y. Cetin Germany	20	548 0.8×	190 0.6×	142 0.5×	303 1.2×	25 0.2×	37	1.6k
A.F. Markham United Kingdom	16	566 0.8×	67 0.2×	194 0.7×	126 0.5×	33 0.3×	35	1.0k
María Ángeles García-López Spain	13	254 0.4×	105 0.3×	92 0.3×	546 2.2×	42 0.3×	20	1.0k
L. Frati Italy	21	830 1.2×	51 0.2×	171 0.6×	413 1.7×	86 0.7×	34	1.5k
Vijaya Chaturvedi United States	24	1.2k 1.8×	45 0.1×	219 0.8×	415 1.7×	61 0.5×	39	2.0k
Yvonne Myal Canada	24	610 0.9×	149 0.5×	73 0.3×	152 0.6×	78 0.6×	55	1.5k
Joonsung Hwang South Korea	22	771 1.1×	60 0.2×	227 0.8×	96 0.4×	22 0.2×	37	1.1k
Lorenza Cannarile Italy	19	558 0.8×	205 0.7×	90 0.3×	801 3.2×	20 0.2×	43	1.6k

Countries citing papers authored by Christopher J. Wraight

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Wraight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Wraight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Wraight more than expected).

Fields of papers citing papers by Christopher J. Wraight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Wraight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Wraight. The network helps show where Christopher J. Wraight may publish in the future.

Co-authorship network of co-authors of Christopher J. Wraight

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Wraight. A scholar is included among the top collaborators of Christopher J. Wraight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Wraight. Christopher J. Wraight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furukawa, Junya, Christopher J. Wraight, Susan M. Freier, et al.. (2009). Antisense oligonucleotide targeting of insulin‐like growth factor‐1 receptor (IGF‐1R) in prostate cancer. The Prostate. 70(2). 206–218. 32 indexed citations

Wilkinson‐Berka, Jennifer L., et al.. (2007). An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.. PubMed. 13. 1529–38. 19 indexed citations

Tachas, George, Shari A. Lofthouse, Christopher J. Wraight, et al.. (2006). A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice. Journal of Endocrinology. 189(1). 147–154. 23 indexed citations

Wilkinson‐Berka, Jennifer L., Christopher J. Wraight, & George A. Werther. (2006). The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy. Current Medicinal Chemistry. 13(27). 3307–3317. 80 indexed citations

Edmondson, Stephanie R., Pritinder Kaur, Rachel Koelmeyer, et al.. (2005). Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo. British Journal of Dermatology. 152(2). 225–230. 35 indexed citations

Adams, Timothy E., et al.. (2005). UV induced responses of the human epidermal IGF system: Impaired anti-apoptotic effects of IGF-I in HaCaT keratinocytes. Growth Factors. 23(2). 151–159. 7 indexed citations

Fogarty, Rhys D., et al.. (2002). Sequence Dependence of C5-Propynyl-dU,dC-Phosphorothioate Oligonucleotide Inhibition of the Human IGF-I Receptor: mRNA, Protein, and Cell Growth. Antisense and Nucleic Acid Drug Development. 12(6). 369–377. 5 indexed citations

White, Paul J., et al.. (2002). C-5 Propyne-Modified Oligonucleotides Penetrate the Epidermis in Psoriatic and Not Normal Human Skin After Topical Application. Journal of Investigative Dermatology. 118(6). 1003–1007. 17 indexed citations

Wraight, Christopher J. & Paul J. White. (2001). Antisense oligonucleotides in cutaneous therapy. Pharmacology & Therapeutics. 90(1). 89–104. 39 indexed citations

10.

Wraight, Christopher J., Paul J. White, Rhys D. Fogarty, et al.. (2000). Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nature Biotechnology. 18(5). 521–526. 66 indexed citations

11.

White, Paul J., Rhys D. Fogarty, George A. Werther, & Christopher J. Wraight. (2000). Antisense Inhibition of IGF Receptor Expression in HaCaT Keratinocytes: A Model for Antisense Strategies in Keratinocytes. Antisense and Nucleic Acid Drug Development. 10(3). 195–203. 12 indexed citations

12.

White, Paul J., et al.. (1999). Live Confocal Microscopy of Oligonucleotide Uptake by Keratinocytes in Human Skin Grafts on Nude Mice. Journal of Investigative Dermatology. 112(6). 887–892. 37 indexed citations

13.

White, Paul J., et al.. (1999). Oligonucleotide Uptake in Cultured Keratinocytes: Influence of Confluence, Cationic Liposomes, and Keratinocyte Cell Type. Journal of Investigative Dermatology. 112(5). 699–705. 25 indexed citations

14.

Edmondson, Stephanie R., Mari Murashita, Vincenzo Russo, Christopher J. Wraight, & George A. Werther. (1999). Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGF?1. Journal of Cellular Physiology. 179(2). 201–207. 38 indexed citations

15.

Wraight, Christopher J., et al.. (1998). Intranuclear Localization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) During Cell Division in Human Keratinocytes. Journal of Investigative Dermatology. 111(2). 239–242. 61 indexed citations

16.

Wraight, Christopher J., Stephanie R. Edmondson, Denys W. Fortune, George Varigos, & George A. Werther. (1997). Expression of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) in the Psoriatic Lesion. Journal of Investigative Dermatology. 108(4). 452–456. 32 indexed citations

17.

Wraight, Christopher J. & George A. Werther. (1995). Insulin-Like Growth Factor-I and Epidermal Growth Factor Regulate Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) in the Human Keratinocyte Cell Line HaCaT. Journal of Investigative Dermatology. 105(4). 602–607. 30 indexed citations

18.

Murashita, Mari, Vincenzo Russo, Stephanie R. Edmondson, Christopher J. Wraight, & George A. Werther. (1995). Identification of insulin‐like growth factor binding proteins from cultured human epidermal keratinocytes. Journal of Cellular Physiology. 163(2). 339–345. 14 indexed citations

19.

Wraight, Christopher J. & Nicholas J. Hoogenraad. (1988). Dietary Regulation of Ornithine Transcarbamylase mRNA in Liver and Small Intestine. Australian Journal of Biological Sciences. 41(4). 435–440. 8 indexed citations

20.

Hoogenraad, Nicholas J., et al.. (1985). Inhibition of intestinal citrulline synthesis causes severe growth retardation in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 249(6). G792–G799. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact